Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma [Phase 2]
A Phase 2 trial of docetaxel, vinorelbine, and sargramostim in metastatic melanoma has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma [Phase 2]
A Phase 2 clinical trial evaluating the immunogenicity of a melanoma peptide vaccine with GM-CSF adjuvant in patients with advanced melanoma…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer [Phase 1]
A Phase 1 study evaluating varlilumab in combination with atezolizumab in patients with advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma
Clinical trial update reporting on the effectiveness and safety of nivolumab administered under the French Temporary Authorization for Use i…
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: A Phase II Study of High Dose Bolus IL2 in Patients With Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy: Efficacy and Biomarker Study [Phase 2]
Phase II study of high-dose bolus interleukin-2 in inoperable stage III/IV melanoma after anti-PD1 failure was terminated; results and bioma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma [Phase 1]
Phase 1 study evaluating safety and preliminary efficacy of combining vemurafenib with high-dose interferon alfa-2b in melanoma has complete…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: Minimally Invasive Groin Dissection for Melanoma [NA]
The clinical trial evaluating minimally invasive groin dissection for melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: Second Echelon Node Study With Methylene Blue [NA]
A Mayo Clinic–sponsored trial evaluating methylene blue for second-echelon sentinel lymph node mapping in breast cancer and melanoma has com…
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients [Phase 2]
A Phase 2 clinical trial combining a peptide vaccine with temozolomide for metastatic melanoma was terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: A Sunscreen Based on Bioadhesive Nanoparticles [Phase 1]
Phase 1 trial of a sunscreen based on bioadhesive nanoparticles conducted by Yale University has completed, assessing safety and early signa…
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene Aberrations [Phase 2]
Phase 2 trial evaluating palbociclib in advanced acral melanoma with cell cycle gene aberrations; the update does not provide efficacy resul…
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
The trial registry entry indicates completion of a study on confocal reflectance microscopy of shave-biopsy skin sites in vivo, including in…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma [Phase 2]
Phase II randomized trial comparing ipilimumab alone to ipilimumab with radiotherapy in metastatic melanoma was terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update for a vaccine therapy in stage III/IV melanoma, completed.
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma [Phase 3]
A Phase 3 trial comparing HDI to chemotherapy as adjuvant systemic therapy for resected mucosal melanoma is ongoing with an unknown status.
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Safety Study of Adjuvant Vaccine to Treat Melanoma Patients [Phase 1, Phase 2]
Safety study update for an adjuvant vaccine in melanoma patients completed phases 1 and 2 with posted results.
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma [Phase 2]
Phase II study investigating KW2871 with high-dose Interferon-α2b in metastatic/cutaneous melanoma completed with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma [Phase 2]
Phase 2 study evaluating epacadostat with a vaccine therapy in patients with stage III-IV melanoma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Interleukin-2 in Metastatic Melanoma [Phase 2]
The Phase 2 trial of Interleukin-2 in metastatic melanoma was terminated; results were posted on 2018-02-07.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma [Phase 2]
Phase 2 trial investigating apatinib in combination with temozolomide for advanced melanoma is underway with an update on study status.
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients [Phase 3]
Phase 3 trial investigating vitamin D supplementation after melanoma surgery was terminated.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) [Phase 2]
Phase 2 trial evaluating intratumoral Hiltonol (poly-ICLC) for solid tumors was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery [Phase 2]
Phase 2 trial update on ipilimumab induction in melanoma patients with brain metastases undergoing stereotactic radiosurgery; study terminat…
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers [Phase 1, Phase 2]
An NCI-sponsored Phase 1/2 study evaluated the combination of imatinib mesylate and bevacizumab in advanced melanoma and other solid tumors,…
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma [Phase 2]
Phase II trial comparing pimasertib to dacarbazine in patients with N-Ras mutated locally advanced or metastatic malignant cutaneous melanom…